Skip to main content
. 2023 Oct 26;8:163. doi: 10.1038/s41541-023-00759-y

Fig. 5. Immunization with SARS-CoV-2 Spike antigen-containing adjuvant formulations results in increased surrogate Virus Neutralization Titer (sVNT).

Fig. 5

Sera from C57BL/6J mice immunized on days 0 and day 21 with excipient, antigen (Ag) alone or formulations containing antigen and various adjuvants were collected on day 42. Surrogate virus neutralizing titers were quantified by measuring inhibition of RBD binding to human ACE2 receptor. (Box-whisker plots: centre line: median; bounds: 25th/75th percentile; whiskers; lowest/highest point) Significance was calculated using a two-way repeated measures ANOVA with Tukey’s multiple comparison testing. N = 4–6 (*p < 0.05, **p < 0.01, ***p < 0.001), ****p < 0.0001).